These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12940065)

  • 1. [Persistent microbial infection and therapeutic vaccine].
    Wen YM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):309-11. PubMed ID: 12940065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock proteins as vaccine adjuvants in infections and cancer.
    Segal BH; Wang XY; Dennis CG; Youn R; Repasky EA; Manjili MH; Subjeck JR
    Drug Discov Today; 2006 Jun; 11(11-12):534-40. PubMed ID: 16713905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cancer through immunization: Prospects and challenges for the 21st century.
    Frazer IH; Lowy DR; Schiller JT
    Eur J Immunol; 2007 Nov; 37 Suppl 1():S148-55. PubMed ID: 17972339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventive animal disease control using vaccines].
    van den Wijngaard JC
    Tijdschr Diergeneeskd; 1987 Aug; 112(15-16):934-40. PubMed ID: 3116719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccines for precancer and cancer of the uterine cervix. II. Therapeutic HPV vaccines].
    Kostova P; Zlatkov V
    Akush Ginekol (Sofiia); 2007; 46(8):31-5. PubMed ID: 18642554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
    Anderson RJ; Schneider J
    Vaccine; 2007 Sep; 25 Suppl 2():B24-34. PubMed ID: 17698262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventative and therapeutic vaccines for cervical cancer.
    Roden R; Wu TC
    Expert Rev Vaccines; 2003 Aug; 2(4):495-516. PubMed ID: 14711335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines.
    Einstein MH
    Cancer Immunol Immunother; 2008 Apr; 57(4):443-51. PubMed ID: 18157723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination.
    Stern PL
    J Clin Virol; 2005 Mar; 32 Suppl 1():S72-81. PubMed ID: 15753015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined immunization with DNA and transduced tumor cells expressing mouse GM-CSF or IL-2.
    Rittich S; Duskova M; Mackova J; Pokorna D; Jinoch P; Smahel M
    Oncol Rep; 2005 Feb; 13(2):311-7. PubMed ID: 15643517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
    J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J; Egan W; Vicari G; Furesz J; Schild G
    Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors involved in the response to microbial pathogens: development of agonists for toll-like receptor 9.
    Schetter C; Vollmer J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):204-10. PubMed ID: 15603254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant viral vectors: cancer vaccines.
    Harrop R; John J; Carroll MW
    Adv Drug Deliv Rev; 2006 Oct; 58(8):931-47. PubMed ID: 17030074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for the prevention of cervical cancer by human papillomavirus vaccination.
    Williamson AL; Passmore JA; Rybicki EP
    Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori.
    Chui SY; Clay TM; Lyerly HK; Morse MA
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1883-9. PubMed ID: 16103431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancer.
    Cui Z; Huang L
    Cancer Immunol Immunother; 2005 Dec; 54(12):1180-90. PubMed ID: 15846491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
    Berinstein NL
    Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.